148 related articles for article (PubMed ID: 1124148)
21. A pilot study of chronic recombinant interferon-alfa 2a for diabetic proliferative retinopathy: metabolic effects and opthalmologic effects.
Skowsky WR; Siddiqui T; Hodgetts D; Lambrou FH; Stewart MW; Foster MT
J Diabetes Complications; 1996; 10(2):94-9. PubMed ID: 8777337
[TBL] [Abstract][Full Text] [Related]
22. The regional distribution of diabetic retinopathy lesions may reflect risk factors for progression of the disease.
Bek T; Helgesen A
Acta Ophthalmol Scand; 2001 Oct; 79(5):501-5. PubMed ID: 11594988
[TBL] [Abstract][Full Text] [Related]
23. Quantifying early diabetic retinopathy.
Howard-Williams JR; Peckar CO; Holman RR; Turner RC; Bron AJ
Diabetologia; 1986 Nov; 29(11):761-6. PubMed ID: 3817334
[TBL] [Abstract][Full Text] [Related]
24. Pituitary ablation for diabetic retinopathy.
Speakman JS; Mortimer CB; Briant TD; Ezrin C; Lougheed WM; Clarke WT
Can Med Assoc J; 1966 Mar; 94(13):627-35. PubMed ID: 5907943
[TBL] [Abstract][Full Text] [Related]
25. Diabetic retinopathy.
Kohner EM; Oakley NW
Metabolism; 1975 Sep; 24(9):1085-102. PubMed ID: 1097858
[TBL] [Abstract][Full Text] [Related]
26. Treatment of diabetic retinopathy: pituitary ablation and retinal photocoagulation.
Balodimos MC
Med Clin North Am; 1971 Jul; 55(4):989-99. PubMed ID: 4946765
[No Abstract] [Full Text] [Related]
27. Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy.
Sharp PS; Fallon TJ; Brazier OJ; Sandler L; Joplin GF; Kohner EM
Diabetologia; 1987 Apr; 30(4):199-207. PubMed ID: 2439401
[TBL] [Abstract][Full Text] [Related]
28. [Naftidrofuryl in the treatment of simple diabetic retinopathy. A double-blind study].
Klein M; Hirche H
Klin Monbl Augenheilkd; 1985 Sep; 187(3):195-201. PubMed ID: 3906248
[TBL] [Abstract][Full Text] [Related]
29. Caclium dobesilate in diabetic retinopathy.
Sévin R; Cuendet JF
Ophthalmologica; 1969; 159(1):126-35. PubMed ID: 5369367
[No Abstract] [Full Text] [Related]
30. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Ophthalmology; 1991 May; 98(5 Suppl):823-33. PubMed ID: 2062515
[TBL] [Abstract][Full Text] [Related]
31. Computer-assisted microaneurysm turnover in the early stages of diabetic retinopathy.
Bernardes R; Nunes S; Pereira I; Torrent T; Rosa A; Coelho D; Cunha-Vaz J
Ophthalmologica; 2009; 223(5):284-91. PubMed ID: 19372722
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics with or without severe microvascular lesions.
Blickle JF; Schlienger JL; de Laharpe F; Stephan F
Diabete Metab; 1982 Sep; 8(3):197-201. PubMed ID: 6814964
[TBL] [Abstract][Full Text] [Related]
33. HYPOPHYSECTOMY FOR THE TREATMENT OF DIABETIC RETINOPATHY.
PEARSON OH; RAY BS; MCLEAN JM; PERETZ WL; GREENBERG E; PAZIANOS A
JAMA; 1964 Apr; 188():116-22. PubMed ID: 14107233
[No Abstract] [Full Text] [Related]
34. [Grading of diabetic retinopathy from non-stereoscopic color fundus photographs--relationship to fluorescein angiography findings and three-year prognosis].
Kitano S
Nippon Ganka Gakkai Zasshi; 2005 Sep; 109(9):563-72. PubMed ID: 16218434
[TBL] [Abstract][Full Text] [Related]
35. Stabilization of severe proliferative diabetic retinopathy by long-term treatment with SMS 201-995.
Mallet B; Vialettes B; Haroche S; Escoffier P; Gastaut P; Taubert JP; Vague P
Diabete Metab; 1992; 18(6):438-44. PubMed ID: 1297600
[TBL] [Abstract][Full Text] [Related]
36. Association between fluorescein leakage and optical coherence tomographic characteristics of microaneurysms in diabetic retinopathy.
Ito H; Horii T; Nishijima K; Sakamoto A; Ota M; Murakami T; Yoshimura N
Retina; 2013 Apr; 33(4):732-9. PubMed ID: 23190917
[TBL] [Abstract][Full Text] [Related]
37. Entoptic evaluation of diabetic retinopathy.
Applegate RA; Bradley A; van Heuven WA; Lee BL; Garcia CA
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):783-91. PubMed ID: 9112972
[TBL] [Abstract][Full Text] [Related]
38. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
[TBL] [Abstract][Full Text] [Related]
39. Capillary microaneurysms and shunt vessels in diabetic retinopathy. Hypothesis on pathogenesis and prevention.
Kornzweig AL
Ann Ophthalmol; 1972 Jul; 4(7):589-94 passim. PubMed ID: 5046463
[No Abstract] [Full Text] [Related]
40. Pattern electroretinograms become abnormal when background diabetic retinopathy deteriorates to a preproliferative stage: possible use as a screening test.
Arden GB; Hamilton AM; Wilson-Holt J; Ryan S; Yudkin JS; Kurtz A
Br J Ophthalmol; 1986 May; 70(5):330-5. PubMed ID: 3964635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
